Abstract
Obstructive sleep apnea (OSA) is a common disorder and the major sleep-related risk factor for cerebrovascular disease. There is a dose-response relationship between the severity of OSA and the odds ratio for development of systemic hypertension. Observational studies have shown that patients with clinically significant OSA have increased incidence of cardiovascular and cerebrovascular disease, as well as increased incidence of sudden death in sleep. Following stroke, patients have a high prevalence of OSA, which diminishes the potential for rehabilitation, increases the risk of secondary stroke, and heightens mortality. Successful treatment of OSA with noninvasive positive airway pressure ventilation and with mandibular advancement devices lowers mean blood pressure. There is suggestive evidence that in patients with advanced OSA, permanent structural cerebral lesions may occur. Circadian changes during sleep contribute to an increase in the risk of cardiovascular and cerebrovascular accidents.
Similar content being viewed by others
References and Recommended Reading
Young T, Palta M, Dempsey J, et al.: The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993, 328:1230–1235.
Culebras A: Balancing sleep and breathing. Stroke 2001, 32:1277–1278.
American Academy of Sleep Medicine: International Classification of Sleep Disorders, edn 2. Diagnostic and Coding Manual. Westchester, Illinois: American Academy of Sleep Medicine; 2005.
Andreotti F, Davies GJ, Hackett DR, et al.: Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke. Am J Cardiol 1988, 62:635–637.
Tofler GH, Brezinsky D, Schafer R, et al.: Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 1987, 316:1514–1515.
Argentino C, Toni D, Rasura M, et al.: Circadian variation in the frequency of ischemic stroke. Stroke 1990, 21:387–389.
Kario K, Shimada K, Pickering TG: Abnormal nocturnal blood pressure falls in elderly hypertension: clinical significance and determinants. J Cardiovasc Pharmacol 2003, 41(Suppl 1):S61–66.
Giles TD: Circadian rhythm of blood pressure and the relation to cardiovascular events. J Hypertens Suppl 2006, 24:S11–16.
Omama S, Yoshida Y, Ogawa A, et al.: Differences in circadian variation of cerebral infarction, intracerebral haemorrhage and subarachnoid haemorrhage by situation at onset. J Neurol Neurosurg Psychiatry 2006, 77:1345–1349.
Marler JR, Price TR, Clark GL, et al.: Morning increase in onset of ischemic stroke. Stroke 1989, 20:473–476.
Marsh EE, Biller J, Adams HP, et al.: Circadian variation in onset of acute ischemic stroke. Arch Neurol 1990, 47:1178–1180.
Guilleminault C: EEG arousals: scoring rules and examples. Sleep 1992, 15:173–184.
Harper RM, Richard CA, Henderson LA, et al.: Structural mechanisms underlying autonomic reactions in pediatric arousal. Sleep Med 2002, 2(Suppl):S53–56.
Cruz-Sánchez FF, Lucena J, Ascaso C, et al.: Cerebellar cortex delayed maturation in sudden infant death syndrome. J Neuropathol Exp Neurol 1997, 56:340–346.
Nieto FJ, Young TB, Lind BK, et al.: Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. JAMA 2000, 283:1829–1836.
Peppard PE, Young T, Palta M, et al.: Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000, 342:1378–1384.
Lavie P, Herer P, Hoffstein V: Obstructive sleep apnea syndrome as a risk factor for hypertension: population study. BMJ 2000, 320:479–482.
Culebras A: REM-sleep related diaphragmatic insufficiency. Neurology 1998, 50(Suppl 4):393–394.
Okosun IS, Prewitt TE, Cooper RS: Abdominal obesity in the United States: prevalence and attributable risk of hypertension. J Hum Hypertens 1999, 13:425–430.
Logan AG, Perlikowski SM, Mente A, et al.: High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 2001, 19:2271–2277.
Sharabi Y, Dagan Y, Grossman E: Sleep apnea as a risk factor for hypertension. Curr Opin Nephrol Hypertens 2004, 13:359–364.
Flemons WW, Remmers JE, Gillis AM: Sleep apnea and cardiac arrhythmias. Is there a relationship? Am Rev Respir Dis 1993, 148:618–621.
Guilleminault C, Pool P, Motta J, Gillis AM: Sinus arrest during REM sleep in young adults. N Engl J Med 1984, 311:1006–1010.
Guilleminault C, Connolly SC, Winkle RA: Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 1983, 52:490–494.
Culebras A: Stroke and sleep disorders. In Current Review of Cerebrovascular Disease, edn 2. Edited by Fisher M, Bogousslavsky J. Philadelphia: Current Medicine; 1996.
Rostagno C, Taddei T, Paladini B, et al.: The onset of symptomatic atrial fibrillation and paroxysmal supraventricular tachycardia is characterized by different circadian rhythms. Am J Cardiol 1993, 71:453–455.
Yamashita T, Murakawa Y, Sezaki K, et al.: Circadian variation of paroxysmal atrial fibrillation. Circulation 1997, 96:1537–1541.
Gami AS, Pressman G, Caples SM, et al.: Association of atrial fibrillation and obstructive sleep apnea. Circulation 2004, 110:364–367.
Mooe T, Gullsby S, Rabben T, et al.: Sleep-disordered breathing: a novel predictor of atrial fibrillation after coronary bypass surgery. Coron Artery Dis 1996, 7:475–478.
Peker Y, Hedner J, Norum E, et al.: Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 2002, 166:159–165.
Naughton MT, Bradley TD: Sleep apnea in congestive heart failure. Clin Chest Med 1998, 19:99–113.
Beelke M, Angeli S, Del Sette M, et al.: Prevalence of patent foramen ovale in subjects with obstructive sleep apnea: a transcranial Doppler ultrasound study. Sleep Med 2003, 4:219–223.
Yokoe T, Minoguchi K, Matsuo H, et al.: Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003, 107:1129–1134.
Svatikova A, Wolk R, Magera MJ, et al.: Plasma homocysteine in obstructive sleep apnoea. Eur Heart J 2004, 25:1325–1329.
Sanner BM, Konermann M, Tepel M, et al.: Platelet function in patients with obstructive sleep apnoea syndrome. Eur Respir J 2000, 16:648–652.
Robinson GV, Pepperell JC, Segal HC, et al.: Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax 2004, 59:777–782.
Netzer N, Werner P, Jochums I, et al.: Blood flow of the middle cerebral artery with sleep-disordered breathing. Correlation with obstructive hypopneas. Stroke 1998, 29:87–93.
Franklin KA: Cerebral hemodynamics in obstructive sleep apnea and Cheyne-Stokes respirations. Sleep Med Rev 2002, 6:429–434.
Neau JP, Paquereau J, Meurice JC, et al.: Auditory event-related potentials before and after treatment with nasal continuous positive airway pressure in sleep apnea syndrome. Eur J Neurol 1996, 3:29–35.
Behrens S, Spengos K, Hennerici M: Acceleration of cerebral blood flow velocity in a patient with sleep apnea and intracranial arterial stenosis. Sleep Breath 2002, 6:111–114.
Marin JM, Carrizo SJ, Vicente E, Agusti AG: Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365:1046–1053.
Yaggi HK, Concato J, Kernan WN, et al.: Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005, 353:2034–2041.
Erkinjuntti T, Partinen M, Sulkava R, et al.: Sleep apnea in multi-infarct dementia and Alzheimer’s disease. Sleep 1987, 10:419–425.
Harbison J, Gibson GJ, Birchall D, et al.: White matter disease and sleep-disordered breathing after acute stroke. Neurology 2003, 61:959–963.
Gami AS, Howard DE, Olson EJ, Somers VK: Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 2005, 352:1206–1214.
Pepperell JC, Ramdassing-Dow S, Crosthwaite N, et al.: Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002, 359:204–210.
Becker H, Jerrentrup A, Ploch T, et al.: Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003, 107:68–73.
Gotsopoulos H, Kelly JJ, Cistulli PA: Oral appliance therapy reduces blood pressure in obstructive sleep apnea: a randomized controlled study. Sleep 2004, 27:934–941.
Giles TL, Lasserson TJ, Smith BH, et al.: Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 2006, 3:CD001106.
Good DC, Henkle JQ, Gelber D, et al.: Sleep-disordered breathing and poor functional outcome after stroke. Stroke 1996, 27:252–259.
Parra O, Arboix A, Bechich S, et al.: Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack. Am J Respir Crit Care Med 2000, 161:375–380.
Hsu CY, Vennelle M, Li HY, et al.: Sleep-disordered breathing after stroke: a randomised controlled trial of continuous positive airway pressure. J Neurol Neurosurg Psychiatry 2006, 77:1143–1149.
Palombini L, Guilleminault C: Stroke and treatment with nasal CPAP. Eur J Neurol 2006, 13:198–200.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Culebras, A. Cerebrovascular disease and the pathophysiology of obstructive sleep apnea. Curr Neurol Neurosci Rep 7, 173–179 (2007). https://doi.org/10.1007/s11910-007-0014-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11910-007-0014-6